Convelo Therapeutics' Unattributed Round

Convelo Therapeutics raised a round of funding on December 05, 2017.

Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin co…

Articles about Convelo Therapeutics' Unattributed Round: